EFPIA Disclosure 2023

Grünenthal Affiliates

As a member of EFPIA, we are fully committed to publishing details about our collaborations with healthcare professionals and healthcare organisations in an ethical and transparent way.

Methodology

The methodological note aims to provide a clear and simple explanation of how Grünenthal collects and discloses relevant information. The note covers definitions of transfers of value, healthcare professionals, healthcare organisations, research and development, data protection and consent topics, general questions about cross-border activities, Value Added Tax (VAT), sponsorships, etc. The methodological note is published yearly, together with the local disclosure files.

Austria

• [Disclosure Austria 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/austria/vhc-report-at-2023.pdf ""/index.html) (pdf, 194 KB)
• [Methodological note - Austria 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/austria/methodische-hinweise-offenlegung-at-2023.pdf ""/index.html) (pdf, 449 KB)

Belgium

• National Registry

Denmark

• National Registry

Finland

• [Disclosure Finland 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/finland/efpia-finland-2023.pdf ""/index.html) (pdf, 131 KB)
• [Methodological note - Finland 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/finland/grunenthal-finland-methodological-note-disclosure-2023.pdf ""/index.html) (pdf, 334 KB)

France

• National Registry

Germany

• [Disclosure Germany 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/germany/fsa-report-2023.pdf ""/index.html) (pdf, 509 KB)
• [Methodological note - Germany 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/germany/methodological-note-gruenenthal-gmbh-2023.pdf ""/index.html) (pdf, 459 KB)

Ireland

• National Registry
• [Methodological note - Ireland 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/ireland/grunenthal-pharma-ltd-methodological-note-2023.pdf ""/index.html) (pdf, 728 KB)

Italy

• [Disclosure Italy 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/italy/efpia-disclosure-italy-2023.pdf ""/index.html) (pdf, 2 MB)
• [Methodological note - Italy 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/italy/disclosure-methodological-note-it-2023.pdf ""/index.html) (pdf, 219 KB)

Luxembourg

• [Disclosure Luxemburg 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/luxemburg/disclosure-report-lux-fr-2023.pdf ""/index.html) (pdf, 616 KB)
• [Methodological note - Luxemburg 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/luxemburg/sa-grunenthal-nv-methodological-note-disclosure-2023.pdf ""/index.html) (pdf, 287 KB)

The Netherlands

• National Registry

Norway

• [Disclosure Norway 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/norway/efpia-norway-2023.pdf ""/index.html) (pdf, 132 KB)
• [Methodological note - Norway 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/norway/grunenthal-norway-methodological-note-disclosure-2023.pdf ""/index.html) (pdf, 338 KB)

Portugal

• National Registry

Spain

• [Disclosure 2023 Spain](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/spain/grunenthal-disclosure-spain-2023.pdf ""/index.html) (pdf, 2 MB)

(Password Transparencia.2023)

• [Methodological Note - Spain 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/spain/gruenenthal-pharma-s-a-nota-metodologica-2023.pdf ""/index.html) (pdf, 340 KB)

Sweden

• [Disclosure Sweden 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/sweden/efpia-sweden-swedish-2023.pdf ""/index.html) (pdf, 143 KB)
• [Methodological note - Sweden 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/sweden/grunenthal-sweden-methodological-note-disclosure-2023.pdf ""/index.html) (pdf, 747 KB)

Switzerland

• [Disclosure 2023 Switzerland](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/switzerland/disclosure-report-ch-2023.pdf ""/index.html) (pdf, 221 KB)
• [Methodological note - Switzerland 2023 DE](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/switzerland/methodological-note-gruenenthal-pharma-ag-2023-de.pdf ""/index.html) (pdf, 241 KB)
• [Methodological note - Switzerland 2023 FR](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/switzerland/methodological-note-gruenenthal-pharma-ag-2023-fr.pdf ""/index.html) (pdf, 261 KB)

UK

• National Registry
• [Disclosure UK 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/uk/2023-grunenthal-tovs-abpi-uk.pdf ""/index.html) (pdf, 1 MB)
• [Methodological note - UK 2023](/content/api/media/project/corporate/groupsitemaster/pdf/tov/2023/uk/disclosure-methodological-note-uk-2023.pdf ""/index.html) (pdf, 218 KB)

Contact Compliance:

In case of any questions please send an email to compliance@grunenthal.com.

If there are questions regarding the disclosure or the data stored by Grünenthal GmbH or a demand that Grünenthal GmbH corrects, blocks or deletes any Personal Data, please contact Grünenthal GmbH in such case under compliance@grunenthal.com.

The given consent for the disclosure of the transfers of values may be revoked at any time without any reason and detrimental effect. Please address your revocation to compliance@grunenthal.com.